ArticlePloS one2026
High prevalence and associated factors of red blood cell folate deficiency among first-trimester pregnant women in a neural tube defect high-risk Region of Tigray, Northern Ethiopia.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe Tigray region of northern Ethiopia has one of the highest reported prevalences of neural tube defects (NTDs) globally. Red blood cell (RBC) folate is the gold-standard biomarker for assessing long-term folate status and predicting the risk of folate-sensitive NTDs. This study assessed RBC folate concentrations and dietary diversity among first-trimester pregnant women in Tigray.
methodsA facility-based cross-sectional study was conducted from March to April 2025 in five randomly selected public hospitals in Tigray, Ethiopia. A total of 400 first-trimester pregnant women (≤13 weeks of gestation) were selected using systematic random sampling. Sociodemographic, anthropometric, obstetric, and dietary data were collected using interviewer-administered questionnaires and a 24-hour dietary recall based on the Food and Agriculture Organization Minimum Dietary Diversity for Women (MDD-W) tool. RBC folate concentrations were measured using electrochemiluminescence immunoassay. Descriptive statistics summarized the data, and an exploratory L2-penalized (Ridge) logistic regression model was fitted because of the rarity of folate sufficiency.
resultsThe mean RBC folate concentration was 221.6 ± 68.6 ng/mL, with a median of 204.9 ng/mL. Overall, 98.8% of participants (395/400; 95% CI: 97.1%-99.6%) had RBC folate concentrations below the WHO-recommended threshold of 400 ng/mL for optimal NTD prevention. Additionally, 79.5% (318/400) of participants did not achieve the minimum dietary diversity threshold (<5 food groups). Among women who achieved minimum dietary diversity, 97.6% (80/82) remained folate deficient. In the exploratory Ridge regression, achieving minimum dietary diversity was positively associated with folate sufficiency (AOR = 1.82), whereas increasing maternal age was inversely associated (AOR = 0.67).
conclusionsThis study demonstrates that maternal RBC folate deficiency was present in almost all first-trimester pregnant women in Tigray, highlighting a substantial public health concern in a region with a high burden of neural tube defects. The finding that clinical deficiency crosses all demographic and dietary tiers indicates that individual-level dietary modification and sporadic supplementation are insufficient to protect maternal reserves. Safely addressing this structural micronutrient emergency and reducing the high burden of NTDs requires an immediate transition toward mandatory, large-scale food fortification of staple grains in Northern Ethiopia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.